1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of patients with carotid blowout syndrome treated with self-expandable stent-grafts
Patient No./Age (y)/Sex Cancer and Treatment History Presentation Blowout Stent-Graft (mm)* Initial Complication† Follow-Up Outcome Onset (y) Group Location 1/35/M Mixed, submandibular gland; wide excision, R/T, C/T Recurrence, RN; lung, kidney metastasis 5 Acute CBF 8 × 50 Asymptomatic acute ICA thrombosis and occlusion Not applicable 19 d: rebleed; died 2/43/M Tonsillar; wide excision, R/T, C/T Recurrence, RN 1 Acute CCA 8 × 30 None Not applicable 2 d: rebleed; died 3/52/M Laryngeal; total laryngectomy, R/T, C/T Recurrence, RN, PCF 4 Acute ICA 7 × 30, 9 × 50 Asymptomatic transient in-stent thrombosis Rebleed wk 3, second stent-graft; patency on 1-mo CTA & 3-mo angiogram 6-mo CT: asymptomatic carotid thrombosis; lived 20 mo 4/49/M Nasopharyngeal, R/T; second primary hypopharyngeal, R/T, C/T Recurrent hypopharyngeal cancer, RN 12, 1 Impending CBF 8 × 50‡ Embolic infarct, MCA territory Stent patency on 1-mo CT, sonography 2-mo: died from progression 5/52/M Hypopharyngeal; R/T, C/T Slightly swollen soft tissue of neck 1 Impending CBF 8 × 50‡ None Stent patency on 2-mo CTA 4-mo: septic carotid thrombosis, brain, abscess; lived 14 mo 6/65/M Laryngeal; R/T RN, PCF 4 Acute CCA, CBF 8 × 50, 8 × 50 None Rebleed at 2-mo, second stent-graft; rebleed at 3-mo, direct percutaneous ECA puncture for embolization; stent patency at 3-mo CT 5-mo CT: asymptomatic carotid thrombosis; lived 13 mo 7/44/M Hypopharyngeal; total laryngopharyngectomy, C/T, R/T Recurrence, RN, PCF, lung metastasis 1/2 Threatened CCA 9 × 70 None Stent patency on 2-wk sonography 1-mo: died from lung metastasis 8/54/M Lower esophageal, primary hypopharyngeal; esophagectomy, laryngectomy, C/T, R/T Recurrence, RN, PCF 1 Threatened CCA 9 × 70 None Stent patency on 2-wk CTA 1.5-mo: died from progression, mediastinitis
Note.—CBF indicates carotid bifurcation; CCA, common carotid artery; C/T, chemotherapy; CTA, CT angiography; ECA, external carotid artery; MCA, middle cerebral artery; PCF, pharyngocutaneous fistula; RN, radiation necrosis; R/T, radiotherapy.
* Wallgraft; Boston Scientific Corporation.
† Immediate hemostasis was achieved in all patients.
‡ Plus 3 fiber coils in the ECA